JOIN US for an exhilarating scientific journey at CICON24 as experts from around the globe convene from September 8-11, 2024, to discuss the latest strides in the dynamic field of cancer immunotherapy.

This year’s meeting includes more than 35 plenary lectures, proffered talks selected from among the submitted abstracts, multiple poster sessions, and exhibits. In nine sessions, we’ll cover the breadth of the field while exploring neoadjuvant and platform trials, we’ll go beyond just atlas-ing in the search for mechanistic insights in multiomic data analysis, tertiary lymphoid aggregates as regulators of anti-cancer immunity, cancer interception, inflammation, metabolism, the microbiome, personalized therapies, and much more. On Sept. 9, meeting co-chair Dana Pe’er, PhD, will moderate a session and panel discussion on the latest and best new tools, technologies and approaches in the field and break through the hype to leverage AI in cancer immunotherapy.